The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Hyperlipidemia as a Risk Factor for Cardiovascular Disease
Open accessAbstract
Synopsis Elevated levels of blood lipids are well documented risk factors for cardiovascular disease. Current classification schemes and treatment levels for hyperlipidemia are based on the National Cholesterol Education Panel’s (NCEP) Adult Treatment Program-3 (ATP-III) guidelines. Statins are the preferred class of drugs to lower elevated low density lipoprotein cholesterol (LDL-C). There are other classes to augment or substitute for statins, such as ezetimibe, fibrates, niacin and dietary supplements. Extensive research over the last decade has raised the question whether or not ATP-III guidelines are sufficiently aggressive. New guidelines from ATP-IV are expected to be released in the near future, but in the meantime physicians are faced with uncertainty about how low to target LDL-C, whether to pharmacologically treat high density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels and how best to achieve target goals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Artichoke leaf extract for treating hypercholesterolaemia
Wider, B., Pittler, M. H., Coon, J. T., & Ernst, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003335.pub3 · Cited by 128
RetractedArtichoke leaf extract for treating hypercholesterolaemia
Wider, B., Pittler, M. H., Coon, J. T., & Ernst, E. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003335.pub2 · Cited by 47
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
The AIM-HIGH Investigators (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107579 · Cited by 2,911
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 1×
“However, recent trials in patients with type 2 diabetes treated with fibrates or niacin have created doubt about this hypothesis (46; 47).”
BackgroundStatins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Nissen, S. E., Nicholls, S. J., Sipahi, I., Libby, P., Raichlen, J. S., Ballantyne, C. M., Davignon, J., Erbel, R., Fruchart, J. C., Tardif, J.-C., et al. (2006) · JAMA · doi:10.1001/jama.295.13.jpc60002 · Cited by 2,047
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Deaths: preliminary data for 2003.
Hoyert, D. L., Kung, H.-C., & Smith, B. L. (2005) · PubMed · Cited by 1,649
Preiss, D. (2011) · JAMA · doi:10.1001/jama.2011.860 · Cited by 1,390
The pathogenesis of atherosclerosis
(1972) · American Heart Journal · doi:10.1016/0002-8703(72)90090-7 · Cited by 1,329
Yeboah, J., McClelland, R. L., Polonsky, T. S., Burke, G. L., Sibley, C. T., O’Leary, D., Carr, J. J., Goff, D. C., Greenland, P., & Herrington, D. M. (2012) · JAMA · doi:10.1001/jama.2012.9624 · Cited by 1,122
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Nicholls, S. J., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., Borgman, M., Wolski, K., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110874 · Cited by 890
Boekholdt, S. M., Arsenault, B. J., Mora, S., Pedersen, T. R., LaRosa, J. C., Nestel, P. J., Simes, R. J., Durrington, P., Hitman, G. A., Welch, K. M. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.366 · Cited by 795
Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy
Cannon, C. P., Steinberg, B. A., Murphy, S. A., Mega, J. L., & Braunwald, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.070 · Cited by 770
National Ambulatory Medical Care Survey: 2001 summary.
Cherry, D. K., Burt, C. W., & Woodwell, D. A. (2003) · PubMed · Cited by 762
Long-term weight loss after diet and exercise: a systematic review
Curioni, C. C., & Lourenço, P. M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803015 · Cited by 695
Lipid-Related Markers and Cardiovascular Disease Prediction
(2012) · JAMA · doi:10.1001/jama.2012.6571 · Cited by 539
Peters, S. A. E., den Ruijter, H. M., Bots, M. L., & Moons, K. G. M. (2012) · Heart · doi:10.1136/heartjnl-2011-300747 · Cited by 415
Garlic for Treating Hypercholesterolemia: A Meta-Analysis of Randomized Clinical Trials
Stevinson, C., Pittler, M. H., & Ernst, E. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-6-200009190-00009 · Cited by 364
Davidson, M. H., Maki, K. C., Pearson, T. A., Pasternak, R. C., Deedwania, P. C., McKenney, J. M., Fonarow, G. C., Maron, D. J., Ansell, B. J., Clark, L. T., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.04.019 · Cited by 270
Steinberg, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400003-jlr200 · Cited by 202
Steinberg, D. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r600009-jlr200 · Cited by 200
Steinberg, D. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r400012-jlr200 · Cited by 185
Balk, E. M., Lau, J., Goudas, L. C., Jordan, H. S., Kupelnick, B., Kim, L. U., & Karas, R. H. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00011 · Cited by 185
Lipid-Modifying Therapies and Risk of Pancreatitis: A Meta-analysis
Preiss, D., Tikkanen, M. J., Welsh, P., Ford, I., Lovato, L. C., Elam, M. B., LaRosa, J. C., DeMicco, D. A., Colhoun, H. M., Goldenberg, I., et al. (2012) · JAMA · doi:10.1001/jama.2012.8439 · Cited by 181 · cited 1×
“In addition, there are questions about a possible link of statins to pancreatitis although a recent review disputes this claim (40).”
BackgroundA Meta-analysis of Randomized Clinical Trials
Crescenzi, G., Landoni, G., Biondi‐Zoccai, G., Pappalardo, F., Nuzzi, M., Bignami, E. G., Fochi, O., Maj, G., Ranucci, M., & Zangrillo, A. (2008) · Cited by 181
Dietary Approaches to the Treatment of Obesity
Makris, A., & Foster, G. D. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.08.004 · Cited by 154 · cited 1×
“In a recent review of various weight loss diets, the authors concluded that the type of diet is less important than the its palatability and the ease of continuing it long term (26).”
BackgroundOosterveer, D. M., Versmissen, J., Yazdanpanah, M., Hamza, T. H., & Sijbrands, E. J. G. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.009 · Cited by 140
Steinberg, D. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500010-jlr200 · Cited by 134
Effect of Two Intensive Statin Regimens on Progression of Coronary Disease
Nicholls, S. J., Ballantyne, C. M., Barter, P. J., Chapman, M. J., Erbel, R. M., Libby, P., Raichlen, J. S., Uno, K., Borgman, M., Wolski, K., et al. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000414260.89578.71 · Cited by 95
Sharma, M., Ansari, M. T., Abou-Setta, A. M., Soares-Weiser, K., Ooi, T. C., Sears, M., Yazdi, F., Tsertsvadze, A., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-9-200911030-00144 · Cited by 79
Kronenberg, H. M., Larsen, P. R., Polonsky, K. S., et al. (2011) · Cited by 74
Steinberg, D. H. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500014-jlr200 · Cited by 57
A Comparative Effectiveness Review
van Rotterdam, J., Hensley, M., & Hazelton, M. (2019) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0000000000000405 · Cited by 47
Comparison of Preventive Effect on Cardiovascular Events With Different Statins - The CIRCLE Study -
Maruyama, T., Takada, M., Nishibori, Y., Fujita, K., Miki, K., Masuda, S., Horimatsu, T., & Hasuike, T. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-1163 · Cited by 42
Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk
Conly, J., Clement, F. M., Tonelli, M. A., Hemmelgarn, B. R., Klarenbach, S. W., Lloyd, A. M., McAlister, F. A., Husereau, D., Wiebe, N., Au, F., et al. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.101281 · Cited by 41
Complementary and Alternative Therapies for the Management of Dyslipidemia
Nies, L. K., Cymbala, A. A., Kasten, S. L., Lamprecht, D. G., & Olson, K. L. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h040 · Cited by 38
Semenkovich, C. F., Goldberg, A. C., & Goldberg, I. J. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00037-7 · Cited by 38
Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy
Aberg, J. A. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2008.11.009 · Cited by 35
Hemphill, L. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.013 · Cited by 25
Use of Emerging Lipoprotein Risk Factors in Assessment of Cardiovascular Risk
Grundy, S. M. (2012) · JAMA · doi:10.1001/jama.2012.6896 · Cited by 23
Drug Class Review: Newer Diabetes Medications, TZDs, and Combinations: Final Original Report
Jonas, D. E., Scoyoc, E. V., Gerrald, K., Wines, R., Amick, H. R., Triplette, M., & Runge, T. M. (2011) · Europe PMC (PubMed Central) · Cited by 20
Comparative Effectiveness of Lipid-Modifying Agents
Sharma, M., Ansari, M., Soares‐Weiser, K., Abou-Setta, A., Tc, O., Sears, M., Yazdi, F., Tsertsvadze, A., & Moher, D. (2009) · Cited by 9
Cited by
Blood-brain barrier dysfunction and recovery after ischemic stroke
Jiang, X., Andjelkovic, A. V., Zhu, L., Yang, T., Bennett, M. V. L., Chen, J., Keep, R. F., & Shi, Y. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.001 · Cited by 936
Quercetin and metabolic syndrome: A review
Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7144 · Cited by 386
Cardiovascular disease and cancer: shared risk factors and mechanisms
Wilcox, N. S., Amit, U., Reibel, J. B., Berlin, E., Howell, K., & Ky, B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01017-x · Cited by 310
Beneficial Effects of Citrus Flavonoids on Cardiovascular and Metabolic Health
Mahmoud, A. M., Hernández Bautista, R. J., Sandhu, M. A., & Hussein, O. E. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/5484138 · Cited by 298
Ahnan‐Winarno, A. D., Cordeiro, L., Winarno, F. G., Gibbons, J., & Xiao, H. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12710 · Cited by 269
Metadata
- Authors
- Nelson, R. H.
- Venue
- Primary Care: Clinics in Office Practice
- Publisher
- Elsevier BV
- Published
- 2013-03
- Volume
- 40
- Issue
- 1
- Pages
- 195-211
- ISSN
- 0095-4543 (ISSN-L)
- OpenAlex
- W2072152755
- Cited by
- 1,093
- References
- 52
- FWCI
- 8.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.